This Plain Language Summary Publication from Future Oncology describes the results from an ongoing study which looks at whether a medication called nivolumab plus chemotherapy works better than chemotherapy alone when given before surgery in people with non–small-cell lung cancer (NSCLC) that can be removed surgically.
Read the full article here.
The original article on which this Plain Language Summary of Publication is based is titled ‘Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer’ and was published in The New England Journal of Medicine. Read the original article here.